Gene · 3161
Papers2,270
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
801 to 820 of 2,270
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| RHAMM in liver metastases of stage IV colorectal cancer with mismatch-repair proficient status correlates with tumor budding, cytotoxic T-cells and PD-1/PD-L1. | Pathol Res Pract | 2021 | 34051513 | PubTator, text mining | PubMed |
| High levels of truncated RHAMM cooperate with dysfunctional p53 to accelerate the progression of pancreatic cancer. | Cancer Lett | 2021 | 34044069 | PubTator, text mining | PubMed |
| Immunotherapy in Acute Myeloid Leukemia: Where We Stand. | Front Oncol | 2021 | 34041025 | PubTator, text mining | PubMed |
| The impact of molecular tumor profiling on the design strategies for targeting myeloid leukemia and EGFR/CD44-positive solid tumors. | Beilstein J Nanotechnol | 2021 | 33981532 | PubTator, text mining | PubMed |
| Integrated profiling identifies ITGB3BP as prognostic biomarker for hepatocellular carcinoma. | Bosn J Basic Med Sci | 2021 | 33974527 | PubTator, text mining | PubMed |
| An Immune-Related lncRNA Expression Profile to Improve Prognosis Prediction for Lung Adenocarcinoma: From Bioinformatics to Clinical Word. | Front Oncol | 2021 | 33968781 | PubTator, text mining | PubMed |
| Transcriptomic analysis and competing endogenous RNA network in the human endometrium between proliferative and mid-secretory phases. | Exp Ther Med | 2021 | 33968190 | PubTator, text mining | PubMed |
| Dual proteome-scale networks reveal cell-specific remodeling of the human interactome. | Cell | 2021 | 33961781 | PubTator, text mining | PubMed |
| Genes That Predict Poor Prognosis in Breast Cancer via Bioinformatical Analysis. | Biomed Res Int | 2021 | 33959662 | PubTator, text mining | PubMed |
| Luminal A Breast Cancer Co-expression Network: Structural and Functional Alterations. | Front Genet | 2021 | 33959148 | PubTator, text mining | PubMed |
| Regulation of amyloid-β levels by matrix metalloproteinase-2/9 (MMP2/9) in the media of lung cancer cells. | Sci Rep | 2021 | 33958632 | PubTator, text mining | PubMed |
| Comprehensive interactome profiling of the human Hsp70 network highlights functional differentiation of J domains. | Mol Cell | 2021 | 33957083 | PubTator, text mining | PubMed |
| Screening and identification of LMNB1 and DLGAP5, two key biomarkers in gliomas. | Biosci Rep | 2021 | 33956061 | PubTator, text mining | PubMed |
| A Glycolysis-Related Five-Gene Signature Predicts Biochemical Recurrence-Free Survival in Patients With Prostate Adenocarcinoma. | Front Oncol | 2021 | 33954109 | PubTator, text mining | PubMed |
| T-cell-based immunotherapy of acute myeloid leukemia: current concepts and future developments. | Leukemia | 2021 | 33953290 | PubTator, text mining | PubMed |
| Promotion of cholangiocarcinoma growth by diverse cancer-associated fibroblast subpopulations. | Cancer Cell | 2021 | 33930309 | PubTator, text mining | PubMed |
| The ECM Modulator ITIH5 Affects Cell Adhesion, Motility and Chemotherapeutic Response of Basal/Squamous-Like (BASQ) Bladder Cancer Cells. | Cells | 2021 | 33924987 | PubTator, text mining | PubMed |
| Deficiency of NEIL3 Enhances the Chemotherapy Resistance of Prostate Cancer. | Int J Mol Sci | 2021 | 33921035 | PubTator, text mining | PubMed |
| Immuno-Oncological Biomarkers for Squamous Cell Cancer of the Head and Neck: Current State of the Art and Future Perspectives. | Cancers (Basel) | 2021 | 33916646 | PubTator, text mining | PubMed |
| Targeting Feedforward Loops Formed by Nuclear Receptor RORγ and Kinase PBK in mCRPC with Hyperactive AR Signaling. | Cancers (Basel) | 2021 | 33916325 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/3161/papers?page=41